5Suppliers
4Customers
2Debt Items
0Related Chains

Source-Backed Evidence Depth

China Pharma Holdings, Inc. (CPHI) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

11Total relationships
4Distinct source URLs
7High confidence
0.794Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

China Pharma Holdings, Inc. Suppliers

TickerNameConfidenceEvidence
JUAN-ZHANG JUAN-ZHANG 90% The Transferor or its designated third party shall provide relevant technical services, which include but are not limited to product research and development, writing of registration materials, regis…
SUPPLIER-A SUPPLIER-A 90% Two suppliers accounted for 37.4 % and 34.2 % of raw material purchases.
SUPPLIER-B SUPPLIER-B 90% Two suppliers accounted for 37.4 % and 34.2 % of raw material purchases.
XIAOYAN-ZHANG XIAOYAN-ZHANG 90% The Transferor or its designated third party shall provide relevant technical services, which include but are not limited to product research and development, writing of registration materials, regis…
XIAOYUN-CHEN XIAOYUN-CHEN 85% The Transferor or its designated third party shall provide relevant technical services, which include but are not limited to product research and development, writing of registration materials, regis…

China Pharma Holdings, Inc. Customers

TickerNameConfidenceEvidence
BIOTECHNOLOGY-CO-LTD BIOTECHNOLOGY-CO-LTD 62% NOTE 13 – COMMITMENTS AND CONTINGENCIES From time to time, the Company and its subsidiaries are parties to various legal actions arising in the ordinary course of business. The Company accrues costs …
CAPITAL-RESOURCES CAPITAL-RESOURCES 62% ance for credit losses as of March 31, 2026 and December 31, 2025: March, 31 December 31, 2026 2025 1 - 180 Days 67.09 % 72.38 % 180 - 365 Days 25.6 % 24.61 % 365 - 720 Days 4.84 % 1.17 % Over 720 Da…
ONNY-INVESTMENT-LIMITED ONNY-INVESTMENT-LIMITED 62% Net loss for the period - - - - ( 1,143,148 ) - ( 1,143,148 ) Foreign currency translation adjustment - - - - - 433,586 433,586 Balance, March 31, 2026 40,522,002 $ 40,522 $ 73,504,819 $ ( 180,000 ) …
RECENT-DEVELOPMENTS-CHINA-PHARMA-HOLDING-INC RECENT-DEVELOPMENTS-CHINA-PHARMA-HOLDING-INC 62% NOTE 13 – COMMITMENTS AND CONTINGENCIES From time to time, the Company and its subsidiaries are parties to various legal actions arising in the ordinary course of business. The Company accrues costs …

China Pharma Holdings, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
CPHI-DEBT-8813 Xbrl Convertible 90% xbrl convertible detail from xbrl 2024-12-31.
CPHI-DEBT Debt stack $6.0M 90% Market cache reports total debt of $6.0M.

China Pharma Holdings, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for China Pharma Holdings, Inc..

China Pharma Holdings, Inc. Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for China Pharma Holdings, Inc..

China Pharma Holdings, Inc. Extended Supply Chain Network

No secondary connectionsNo correlated companies found through shared supply chain relationships.
🔐
CPHI
Unlock CPHI Supply Chain Data
Verified relationships include:
JUAN-ZHANGJUAN-ZHANGSupplier90%
SUPPLIER-ASUPPLIER-ASupplier90%
BIOTECHNOLOGY-CO-LTDBIOTECHNOLOGY-CO-LTDCustomer62%
CAPITAL-RESOURCESCAPITAL-RESOURCESCustomer62%
+7 more relationships locked
Subscribe — View plans →